ES2196028T3 - Liposomas fusogenicos y metodos de fabricacion y utilizacion. - Google Patents
Liposomas fusogenicos y metodos de fabricacion y utilizacion.Info
- Publication number
- ES2196028T3 ES2196028T3 ES94919976T ES94919976T ES2196028T3 ES 2196028 T3 ES2196028 T3 ES 2196028T3 ES 94919976 T ES94919976 T ES 94919976T ES 94919976 T ES94919976 T ES 94919976T ES 2196028 T3 ES2196028 T3 ES 2196028T3
- Authority
- ES
- Spain
- Prior art keywords
- liposoma
- lipidic
- external
- lipid
- fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002502 liposome Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 150000002632 lipids Chemical class 0.000 abstract 5
- 230000004927 fusion Effects 0.000 abstract 4
- 239000007788 liquid Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000000232 Lipid Bilayer Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
SE FACILITA UN COMPUESTO DE LIPOSOMAS QUE CONTIENE UN LIPOSOMA QUE INCLUYE :(I) UNA BICAPA LIPIDICA EN SU PARTE MAS EXTERIOR QUE CONTIENE, ADEMAS DE UN LIPIDO PREFERIBLEMENTE BICAPADO NEUTRAL, UNA CANTIDAD EFECTIVA QUE FACILITE LA FUSION DE UN LIPIDO IONIZABLE QUE TENGA UNA CABECERA CATIONICA, GENERADORA DE PROTONES Y UNA CADENA DE ACIL INSATURADO; Y (II) UN COMPARTIMENTO ADYACENTE A LA BICAPA LIPIDICA EXTERIOR QUE CONTIENE UNA SOLUCION ACUOSA CON UN PRIMER PH. FUERA DEL LIPOSOMA EN LA COMPOSICION HAY UNA SOLUCION ACUOSA CON UN SEGUNDO PH. EL PRIMER PH ES INFERIOR AL PK{SUB,A} DEL LIPIDO IONIZABLE DE LA BICAPA LIPIDICA EXTERIOR Y EL SEGUNDO PH ES MAYOR QUE EL PK{SUB,A} DE UN LIPIDO IONIZABLE DE LA BICAPA LIPIDICA EXTERIOR, COMO PUEDE SER EL QUE EXISTE EN UN GRADIENTE DE PH A TRAVES DE LA BICAPA LIPIDICA EXTERIOR, ACUMULANDOSE EL LIPIDO IONIZABLE EN LA MONOCAPA INTERIOR DE LA BICAPA LIPIDICA EXTERIOR QUE RESPONDE AL GRADIENTE. EL LIPOSOMA PUEDE FUNDIRSE DE FORMA CONTROLADA CON OTRA BICAPA LIPIDICA, COMO POR EJEMPLO, LA MEMBRANA PLASMATICA DE LA CELULA DE UN MAMIFERO, MEDIANTE EL DEGRADADO DEL GRADIENTE DE PH CUANDO SE PRODUCE LA FUSION, DE FORMA QUE EL LIPIDO IONIZABLE ES NEUTRAL, INCLUSO CUANDO SE DISTRIBUYE EN LA BICAPA LIPIDICA EXTERIOR Y, FUSOGENICO. LA FUSION CONTROLADA PUEDE USARSE PARA CONTROLAR EL ENVIO DE UN AGENTE ACTIVO BIOLOGICAMENTE DENTRO DEL LIPOSOMA AL INTERIOR DE UNA CELULA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1994/003996 WO1995027478A1 (en) | 1994-04-12 | 1994-04-12 | Fusogenic liposomes and methods of making and using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2196028T3 true ES2196028T3 (es) | 2003-12-16 |
Family
ID=22242444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94919976T Expired - Lifetime ES2196028T3 (es) | 1994-04-12 | 1994-04-12 | Liposomas fusogenicos y metodos de fabricacion y utilizacion. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0758883B1 (es) |
| JP (1) | JP3804025B2 (es) |
| KR (1) | KR100315132B1 (es) |
| AT (1) | ATE234605T1 (es) |
| AU (1) | AU689479B2 (es) |
| CA (1) | CA2187748C (es) |
| DE (1) | DE69432320T2 (es) |
| DK (1) | DK0758883T3 (es) |
| ES (1) | ES2196028T3 (es) |
| FI (1) | FI964083A7 (es) |
| NO (1) | NO318814B1 (es) |
| NZ (1) | NZ268146A (es) |
| WO (1) | WO1995027478A1 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0964690B1 (en) * | 1996-10-15 | 2003-07-09 | The Liposome Company, Inc. | Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| US6339069B1 (en) | 1996-10-15 | 2002-01-15 | Elan Pharmaceuticalstechnologies, Inc. | Peptide-lipid conjugates, liposomes and lipsomal drug delivery |
| US6835395B1 (en) | 1997-05-14 | 2004-12-28 | The University Of British Columbia | Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles |
| WO1998051278A2 (en) | 1997-05-14 | 1998-11-19 | Inex Pharmaceuticals Corporation | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| US6613352B2 (en) | 1999-04-13 | 2003-09-02 | Universite De Montreal | Low-rigidity liposomal formulation |
| CN100368020C (zh) * | 1999-08-27 | 2008-02-13 | 不列颠哥伦比亚大学 | 用于刺激细胞因子分泌和诱导免疫应答的组合物 |
| JP2007524604A (ja) * | 2003-03-31 | 2007-08-30 | アルザ・コーポレーシヨン | 非対称の脂質被膜を有する脂質粒子およびその製造方法 |
| CA2595003C (en) | 2005-01-28 | 2011-03-15 | Japan Science And Technology Agency | Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| EP3494964B1 (en) * | 2007-05-14 | 2021-04-07 | Konica Minolta Holdings, Inc. | Liposome and method for producing liposome |
| EP4241767B1 (en) | 2008-11-10 | 2024-10-23 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| US9937128B2 (en) * | 2009-08-03 | 2018-04-10 | The University Of North Carolina At Chapel Hill | Liposomes comprising a calcium phosphate-containing precipitate |
| PL3338765T3 (pl) | 2009-12-01 | 2019-06-28 | Translate Bio, Inc. | Pochodna steroidowa dla dostarczania mrna w ludzkich chorobach genetycznych |
| PT2717893T (pt) | 2011-06-08 | 2019-08-20 | Translate Bio Inc | Composições de nanopartículas lipídicas e métodos para transferência de arnm |
| WO2013185067A1 (en) | 2012-06-08 | 2013-12-12 | Shire Human Genetic Therapies, Inc. | Nuclease resistant polynucleotides and uses thereof |
| ES2981185T3 (es) | 2013-03-14 | 2024-10-07 | Translate Bio Inc | Métodos para la purificación de ARN mensajero |
| EP2968586B1 (en) | 2013-03-14 | 2018-07-25 | Translate Bio, Inc. | Cftr mrna compositions and related methods and uses |
| MX2016005239A (es) | 2013-10-22 | 2016-08-12 | Shire Human Genetic Therapies | Tratamiento con acido ribonucleico mensajero para la fenilcetonuria. |
| US11224642B2 (en) | 2013-10-22 | 2022-01-18 | Translate Bio, Inc. | MRNA therapy for argininosuccinate synthetase deficiency |
| JP6571679B2 (ja) | 2014-04-25 | 2019-09-04 | トランスレイト バイオ, インコーポレイテッド | メッセンジャーrnaの精製方法 |
| AU2018224326B2 (en) | 2017-02-27 | 2024-01-04 | Translate Bio, Inc. | Novel codon-optimized CFTR mRNA |
| MX2019013752A (es) | 2017-05-16 | 2020-07-20 | Translate Bio Inc | Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones. |
| CN118421617A (zh) | 2018-08-24 | 2024-08-02 | 川斯勒佰尔公司 | 用于纯化信使rna的方法 |
| EP3883592A1 (en) | 2018-11-21 | 2021-09-29 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of nebulized mrna encoding cftr |
| WO2021055609A1 (en) | 2019-09-20 | 2021-03-25 | Translate Bio, Inc. | Mrna encoding engineered cftr |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946787A (en) * | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| EP0269720B1 (en) * | 1986-06-16 | 1992-02-19 | The Liposome Company, Inc. | Induction of asymmetry in vesicles |
| JPH0395118A (ja) * | 1989-09-07 | 1991-04-19 | Green Cross Corp:The | プロスタグランジン含有脂肪小体製剤 |
| DE4013632A1 (de) * | 1990-04-27 | 1991-10-31 | Max Planck Gesellschaft | Liposomen mit positiver ueberschussladung |
| US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
-
1994
- 1994-04-12 AU AU70915/94A patent/AU689479B2/en not_active Ceased
- 1994-04-12 DE DE69432320T patent/DE69432320T2/de not_active Expired - Fee Related
- 1994-04-12 ES ES94919976T patent/ES2196028T3/es not_active Expired - Lifetime
- 1994-04-12 EP EP94919976A patent/EP0758883B1/en not_active Expired - Lifetime
- 1994-04-12 NZ NZ268146A patent/NZ268146A/en not_active IP Right Cessation
- 1994-04-12 CA CA002187748A patent/CA2187748C/en not_active Expired - Fee Related
- 1994-04-12 JP JP52630695A patent/JP3804025B2/ja not_active Expired - Fee Related
- 1994-04-12 WO PCT/US1994/003996 patent/WO1995027478A1/en not_active Ceased
- 1994-04-12 AT AT94919976T patent/ATE234605T1/de not_active IP Right Cessation
- 1994-04-12 KR KR1019960705605A patent/KR100315132B1/ko not_active Expired - Fee Related
- 1994-04-12 DK DK94919976T patent/DK0758883T3/da active
-
1996
- 1996-10-09 NO NO19964284A patent/NO318814B1/no unknown
- 1996-10-11 FI FI964083A patent/FI964083A7/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69432320D1 (de) | 2003-04-24 |
| AU7091594A (en) | 1995-10-30 |
| EP0758883A1 (en) | 1997-02-26 |
| FI964083A0 (fi) | 1996-10-11 |
| NO964284D0 (no) | 1996-10-09 |
| NO964284L (no) | 1996-10-09 |
| DK0758883T3 (da) | 2003-06-02 |
| EP0758883B1 (en) | 2003-03-19 |
| AU689479B2 (en) | 1998-04-02 |
| NZ268146A (en) | 1997-10-24 |
| CA2187748A1 (en) | 1995-10-19 |
| WO1995027478A1 (en) | 1995-10-19 |
| DE69432320T2 (de) | 2003-12-04 |
| JPH09511521A (ja) | 1997-11-18 |
| CA2187748C (en) | 2007-04-10 |
| KR100315132B1 (ko) | 2002-06-26 |
| JP3804025B2 (ja) | 2006-08-02 |
| NO318814B1 (no) | 2005-05-09 |
| FI964083A7 (fi) | 1996-10-11 |
| ATE234605T1 (de) | 2003-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2148568T3 (es) | Formulaciones de disoluciones acuosas estables de interferon alfa. | |
| ES2162638T3 (es) | Vehiculos de suministro de farmacos con gelificacion termica que contienen eteres de celulosa. | |
| AR015560A1 (es) | Producto de papel tisu suave | |
| Cereijido et al. | Fluxes and distribution of sodium in frog skin: a new model | |
| CO5050344A1 (es) | Composicion dentifrica que contiene ingredientes reactivos encapsulados | |
| ES2039898T3 (es) | Acondicionamiento para una composicion liquida lista para su uso realizada a partir de una composicion liquida concentrada y procedimiento de realizacion. | |
| ES2017187A6 (es) | Electrodo de iontoforesis. | |
| PT97140A (pt) | Dispositivo para a administracao de substancias activas farmaceuticas por electroforese ionica | |
| ES2129980T3 (es) | Sistema de afeitado en humedo con un material compuesto que favorece el afeitado, con un complejo de inclusion de un agente suavizante de la piel y ciclodextrina. | |
| AR020633A1 (es) | Parche cosmetico, farmaceutico o dermatologico. | |
| NO964284L (no) | Fusogene liposomer og fremgangsmåter for fremstilling og anvendelse derav | |
| PE106898A1 (es) | Composicion liquida de aseo personal que contiene un agente humectante de piel lipofilico compuesto de gotitas relativamente grandes | |
| ES2177677T3 (es) | Soluciones estables de 2-cloro-2`desoxiadenosina. | |
| AR035509A1 (es) | Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento | |
| BR9807646A (pt) | Composição concentrada desinfetante lìquida aquosa, e, composição desinfetante. | |
| SE9704386D0 (sv) | Flerkammarbehållare för medicinsk lösning | |
| AU2006238138A1 (en) | External preparation, method of applying external preparation, iontophoresis device and transdermal patch | |
| ES2192256T3 (es) | Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas. | |
| ATE273033T1 (de) | Stabilisierte ophthalmische wasserstoffperoxidlösung | |
| ES8900197A1 (es) | Procedimiento para la preparacion de liposomas a partir de una mezcla de un componente lipido y agua | |
| ES2186743T3 (es) | Celda de medida electroquimica. | |
| TR199903211T2 (xx) | Azasteroitler içeren çözeltiler. | |
| US6740330B1 (en) | Method of treating acne vulgaris and composition | |
| DE60109322D1 (de) | Stabiles hautpflegemittel das ein retinoid und ein retinoid-verstärkendes system enthält in einer zweikammerverpackung | |
| ES2084598T3 (es) | Composiciones detergentes liquidas. |